The Fort Worth Press - Formerra to Supply Foster Medical Compounds in Europe

USD -
AED 3.6725
AFN 64.498133
ALL 81.906187
AMD 374.313495
ANG 1.789761
AOA 916.99974
ARS 1370.732402
AUD 1.421535
AWG 1.8
AZN 1.701965
BAM 1.67181
BBD 2.013215
BDT 122.927663
BGN 1.673517
BHD 0.377423
BIF 2972.71076
BMD 1
BND 1.274923
BOB 6.906721
BRL 5.028498
BSD 0.999598
BTN 93.233893
BWP 13.474089
BYN 2.852527
BYR 19600
BZD 2.0103
CAD 1.384525
CDF 2299.999634
CHF 0.791005
CLF 0.022832
CLP 898.599436
CNY 6.827991
CNH 6.832625
COP 3647.36
CRC 461.844214
CUC 1
CUP 26.5
CVE 94.25366
CZK 20.86425
DJF 177.993375
DKK 6.39568
DOP 60.100695
DZD 132.357984
EGP 53.134404
ERN 15
ETB 156.846843
EUR 0.85585
FJD 2.215904
FKP 0.743222
GBP 0.745075
GEL 2.69029
GGP 0.743222
GHS 11.019934
GIP 0.743222
GMD 73.484664
GNF 8771.022545
GTQ 7.647004
GYD 209.124907
HKD 7.831896
HNL 26.550813
HRK 6.446976
HTG 130.894326
HUF 314.012978
IDR 17188
ILS 3.06281
IMP 0.743222
INR 93.33055
IQD 1309.461735
IRR 1316125.000089
ISK 122.559635
JEP 0.743222
JMD 157.795311
JOD 0.708973
JPY 159.830495
KES 129.502631
KGS 87.45022
KHR 4002.991773
KMF 419.999886
KPW 899.999618
KRW 1490.449993
KWD 0.30906
KYD 0.832995
KZT 475.050753
LAK 22043.380703
LBP 89510.759697
LKR 315.426862
LRD 183.917085
LSL 16.520895
LTL 2.95274
LVL 0.60489
LYD 6.350251
MAD 9.285949
MDL 17.082167
MGA 4149.161235
MKD 52.699069
MMK 2100.298181
MNT 3573.374694
MOP 8.062656
MRU 39.887167
MUR 46.529738
MVR 15.460115
MWK 1733.262101
MXN 17.391402
MYR 3.974979
MZN 63.960044
NAD 16.520895
NGN 1360.060206
NIO 36.781865
NOK 9.499495
NPR 149.174057
NZD 1.71864
OMR 0.384503
PAB 0.999594
PEN 3.389095
PGK 4.392796
PHP 60.245981
PKR 278.802778
PLN 3.641099
PYG 6408.404353
QAR 3.643995
RON 4.357898
RSD 100.467022
RUB 76.176004
RWF 1463.831606
SAR 3.75278
SBD 8.058149
SCR 13.932132
SDG 600.999759
SEK 9.322095
SGD 1.27625
SHP 0.746601
SLE 24.625032
SLL 20969.499962
SOS 571.257613
SRD 37.449051
STD 20697.981008
STN 20.942498
SVC 8.746234
SYP 110.528533
SZL 16.508601
THB 32.289497
TJS 9.475884
TMT 3.505
TND 2.916991
TOP 2.40776
TRY 44.72233
TTD 6.787905
TWD 31.80303
TZS 2594.05402
UAH 43.42568
UGX 3733.748194
UYU 40.337815
UZS 12124.372262
VES 475.837802
VND 26343
VUV 119.309373
WST 2.73449
XAF 560.706913
XAG 0.013479
XAU 0.000212
XCD 2.70255
XCG 1.801475
XDR 0.697817
XOF 560.706913
XPF 101.942515
YER 237.150205
ZAR 16.59331
ZMK 9001.205244
ZMW 19.016562
ZWL 321.999592
  • CMSC

    -0.0020

    22.428

    -0.01%

  • BCC

    -1.0700

    79.1

    -1.35%

  • RIO

    0.1900

    98.45

    +0.19%

  • NGG

    -1.9600

    88.33

    -2.22%

  • CMSD

    0.0400

    22.67

    +0.18%

  • JRI

    -0.0350

    12.985

    -0.27%

  • RELX

    0.4650

    33.765

    +1.38%

  • BCE

    -0.0210

    23.329

    -0.09%

  • RYCEF

    -0.2700

    16.96

    -1.59%

  • BTI

    -0.0050

    58.805

    -0.01%

  • VOD

    -0.1150

    15.575

    -0.74%

  • AZN

    -2.7300

    201.3

    -1.36%

  • BP

    0.3350

    46.775

    +0.72%

  • GSK

    0.0500

    58.26

    +0.09%

  • RBGPF

    -13.5000

    69

    -19.57%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

B.Martinez--TFWP